It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Extracellular vesicles (EVs) are membranous vesicles that are released by cells. In this study, the role of the Endosomal Sorting Complex Required for Transport (ESCRT) machinery in the biogenesis of yeast EVs was examined. Knockout of components of the ESCRT machinery altered the morphology and size of EVs as well as decreased the abundance of EVs. In contrast, strains with deletions in cell wall biosynthesis genes, produced more EVs than wildtype. Proteomic analysis highlighted the depletion of ESCRT components and enrichment of cell wall remodelling enzymes, glucan synthase subunit Fks1 and chitin synthase Chs3, in yeast EVs. Interestingly, EVs containing Fks1 and Chs3 rescued the yeast cells from antifungal molecules. However, EVs from fks1∆ or chs3∆ or the vps23∆chs3∆ double knockout strain were unable to rescue the yeast cells as compared to vps23∆ EVs. Overall, we have identified a potential role for yeast EVs in cell wall remodelling.
Kening Zhao et al. show that yeast extracellular vesicles are depleted of ESCRT proteins but enriched with Fks1 and Chs3. The toxic effect of antifungal agents can be diminished by exposure to the Fks1- and Chs3- rich extracellular vesicles, suggesting a role for yeast extracellular vesicles in cell wall remodelling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 La Trobe University, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938)
2 La Trobe University, Department of Computer Science and Information Technology, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938)
3 La Trobe University, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938); Peter MacCallum Cancer Centre, Cancer Research Division, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000000403978434); University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
4 University of Melbourne, Bio21 Institute, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
5 The University of Adelaide, Waite Campus, ARC Centre of Excellence in Plant Cell Walls and Adelaide Glycomics, Urrbrae, Australia (GRID:grid.1010.0) (ISNI:0000 0004 1936 7304)